For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $21.44 in the prior trading day, Caredx Inc (NASDAQ: CDNA) closed at $22.70, up 5.88%. In other words, the price has increased by $5.88 from its previous closing price. On the day, 1.02 million shares were traded. CDNA stock price reached its highest trading level at $22.78 during the session, while it also had its lowest trading level at $21.3125.
Ratios:
Our goal is to gain a better understanding of CDNA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 997.94. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when Novack Jeffrey Adam sold 1,917 shares for $26.00 per share. The transaction valued at 49,842 led to the insider holds 110,237 shares of the business.
Jeffrey Adam Novack bought 1,917 shares of CDNA for $47,848 on Dec 04 ’24. On Nov 26 ’24, another insider, Maag Peter, who serves as the Director of the company, sold 5,000 shares for $25.00 each. As a result, the insider received 125,000 and left with 330,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1217489536 and an Enterprise Value of 1006600896. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.89 while its Price-to-Book (P/B) ratio in mrq is 4.41. Its current Enterprise Value per Revenue stands at 3.218 whereas that against EBITDA is -22.745.
Stock Price History:
The Beta on a monthly basis for CDNA is 1.87, which has changed by 1.1612904 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -1.02%, while the 200-Day Moving Average is calculated to be 9.30%.
Shares Statistics:
The stock has traded on average 792.60K shares per day over the past 3-months and 984360 shares per day over the last 10 days, according to various share statistics. A total of 53.11M shares are outstanding, with a floating share count of 50.22M. Insiders hold about 6.36% of the company’s shares, while institutions hold 97.11% stake in the company. Shares short for CDNA as of 1735603200 were 3969771 with a Short Ratio of 5.01, compared to 1732838400 on 3337432. Therefore, it implies a Short% of Shares Outstanding of 3969771 and a Short% of Float of 9.7600006.
Earnings Estimates
The dynamic stock of Caredx Inc (CDNA) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.08, with high estimates of $0.12 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.54 and $0.42 for the fiscal current year, implying an average EPS of $0.47. EPS for the following year is $0.56, with 5.0 analysts recommending between $0.71 and $0.46.
Revenue Estimates
4 analysts predict $84M in revenue for the current quarter. It ranges from a high estimate of $85.5M to a low estimate of $82.5M. As of the current estimate, Caredx Inc’s year-ago sales were $65.57MFor the next quarter, 4 analysts are estimating revenue of $86.01M. There is a high estimate of $89.2M for the next quarter, whereas the lowest estimate is $83.9M.
A total of 3 analysts have provided revenue estimates for CDNA’s current fiscal year. The highest revenue estimate was $332.7M, while the lowest revenue estimate was $330M, resulting in an average revenue estimate of $331.8M. In the same quarter a year ago, actual revenue was $280.32MBased on 5 analysts’ estimates, the company’s revenue will be $369.22M in the next fiscal year. The high estimate is $370.22M and the low estimate is $368M.
